Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$343K Sell
5,458
-6,500
-54% -$453K ﹤0.01% 615
2025
Q4
$794K Buy
11,958
+2,200
+23% +$142K ﹤0.01% 574
2025
Q3
$657K Buy
+9,758
New +$772K ﹤0.01% 591
2025
Q1
Sell
-7,703
Closed -$599K 683
2024
Q4
$599K Buy
+7,703
New +$570K ﹤0.01% 609
2024
Q3
Sell
-56,753
Closed -$6.43M 684
2024
Q2
$6.43M Buy
+56,753
New +$7.18M 0.04% 238
2023
Q4
Sell
-11,830
Closed -$1.1M 739
2023
Q3
$1.1M Sell
11,830
-1,467
-11% -$165K 0.01% 543
2023
Q2
$1.71M Buy
+13,297
New +$1.61M 0.01% 480

Other funds holding DXCM

AGF Management's DXCM Position: Q1 2026 in Review

AGF Management reduced its DexCom (DXCM) stake by 54% in Q1 2026, selling an estimated $453K and leaving 5,458 shares worth $343K. The position accounts for ﹤0.01% of the portfolio, ranked #615.

AGF Management first reported a position in DXCM in Q2 2023 and has held it in 7 quarters since. The position peaked at $6.43M in Q2 2024. 956 funds tracked by Wall St. Rank hold DXCM as of Q1 2026.

  • AGF Management held 5,458 shares of DexCom worth $343K as of Q1 2026.
  • AGF Management sold 6,500 DexCom shares in Q1 2026, an estimated $453K.
  • DexCom made up ﹤0.01% of AGF Management's portfolio in Q1 2026, its #615 holding.
  • AGF Management first reported a position in DexCom in Q2 2023 and has held it in 7 quarters since.
  • AGF Management's DexCom position peaked at $6.43M in Q2 2024.
  • 956 funds tracked by Wall St. Rank held DexCom as of Q1 2026.

Based on AGF Management's 13F filing for Q1 2026, filed 7 May 2026.